Gernandt & Danielsson advises in relation to Immunicum AB’s private placement and rights issue

Gernandt & Danielsson has advised Immunicum AB and Pareto Securities AB (financial adviser to Immunicum) in a SEK 56 million private placement of shares in Immunicum and a subsequent rights issue in an amount of approximately SEK 44 million.

Immunicum is a biopharmaceutical company developing therapeutic cancer vaccines. Immunicum’s shares are traded on NASDAQ OMX First North.

Gernandt & Danielsson’s team consisted of partner Carl Westerberg, senior associate Gustav Skogö and associate Oscar Anderson.